Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g;Hydrocortisone / oxytetracycline hydrochloride, ointment, 10 mg/g / 30 mg/g, 15 g each;Ornidazole solution for infusions, 5 mg/ml, 100 ml each;Miramistin eye/ear/nasal drops 0.1 mg/ml 5 ml;Sodium adenosine triphosphate solution for injection 10 mg/ml in 1 ml;Pentoxifylline, solution for injection, 20 mg/ml, 5 ml each;Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule;Cefoperazone, powder for injection 1 g;Lipoic acid soluti
By: Lyudmila Romanchuk📍 UkraineOpen
Key Information
| Reference | GB-UA-2026-11-12-010208-a |
|---|
| Deadline | Nov 17, 2026 12:00 AM |
|---|
| Estimated Value | UAH 253,771,300.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 33027, Ukraine, Rivne region, Rivne, st.Kyivska, 78 |
|---|
| Published | Nov 12, 2026 |
|---|
Description
Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g;Hydrocortisone / oxytetracycline hydrochloride, ointment, 10 mg/g / 30 mg/g, 15 g each;Ornidazole solution for infusions, 5 mg/ml, 100 ml ea...
Full details are available after unlocking this tender.